The company said that through its wholly-owned subsidiary, InnoCan Pharma Limited (InnoCan Israel), it has signed key agreements with top global companies for the fulfillment, logistics, and service of the website.
The new website offers a user-friendly experience with excellent navigation and functionality, allowing consumers to see full product information. The online product distribution will be handled by Brandzon Company Limited, a specialist in e-commerce growth and worldwide acceleration. The Brandzon team has a proven sales track record worldwide, with global third-party logistics (3PL) capabilities.
In a statement, Roni Kamhi, CEO and co-founder of Brandzon said: "InnoCan is a leading innovative pharmaceutical company that has the potential to bring an advanced formulated product into the skincare market with the science to back it.”
“Together we can achieve success in the e-commerce space and generate revenue for both companies."
In the meantime, InnoCan Pharma founder CEO Iris Bincovich said the company was “very pleased” to unveil its new website.
"The site will allow consumers to browse smoothly through our product collection and find the perfect product that will meet their requirements,” added Bincovich.
“This is a major milestone and a great opportunity for Innocan to start with B2C operation that will secure a new and sustainable source of income for the company."
Innocan, through its wholly-owned Israeli subsidiary Innocan Pharma Ltd, is a pharmaceutical tech company that focuses on the development of several drug delivery platforms combining cannabidiol, or CBD.
The Israeli firm markets a line of premium CBD-infused derma cosmetic products, the SHIR Beauty & Science skincare brand that is distributed throughout the UK, Ireland and many other countries.
Contact the author Uttara Choudhury at email@example.com
Follow her on Twitter: @UttaraProactive